Foghorn Therapeutics Inc. financial data

Symbol
FHTX on Nasdaq
Location
500 Technology Square, Suite 700, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 287 % -38.3%
Debt-to-equity -456 % +29%
Return On Equity 105 % -37.2%
Return On Assets -29.6 % +4.39%
Operating Margin -353 % +13.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.6M shares +1.72%
Common Stock, Shares, Outstanding 56.5M shares +1.71%
Entity Public Float 205M USD +2.4%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 63M shares +0.68%
Weighted Average Number of Shares Outstanding, Diluted 63M shares +0.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 24.5M USD -3.91%
Research and Development Expense 83.9M USD -14.6%
General and Administrative Expense 27.1M USD -6.62%
Operating Income (Loss) -86.5M USD +16.9%
Nonoperating Income (Expense) 14.4M USD -3.39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -86.6M USD +8.05%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -72.1M USD +20.9%
Earnings Per Share, Basic -1 USD/shares +44.8%
Earnings Per Share, Diluted -1 USD/shares +44.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89.3M USD +54.9%
Assets, Current 184M USD -32.1%
Operating Lease, Right-of-Use Asset 10.2M USD -57.7%
Other Assets, Noncurrent 5K USD -99.4%
Assets 205M USD -33.5%
Accounts Payable, Current 3.21M USD -6.93%
Employee-related Liabilities, Current 4.24M USD +12.4%
Accrued Liabilities, Current 9.82M USD -12.5%
Contract with Customer, Liability, Current 65.3M USD +95.6%
Liabilities, Current 85.1M USD +49.7%
Contract with Customer, Liability, Noncurrent 193M USD -22.6%
Operating Lease, Liability, Noncurrent 15.8M USD -47.9%
Other Liabilities, Noncurrent 656K USD
Liabilities 295M USD -12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 24K USD -93.3%
Retained Earnings (Accumulated Deficit) -611M USD -13.4%
Stockholders' Equity Attributable to Parent -89.7M USD -217%
Liabilities and Equity 205M USD -33.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24M USD +18.3%
Net Cash Provided by (Used in) Financing Activities 139K USD -88.1%
Net Cash Provided by (Used in) Investing Activities 29.4M USD +8.51%
Common Stock, Shares Authorized 175M shares 0%
Common Stock, Shares, Issued 56.5M shares +1.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.08M USD +31.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 92.6M USD +55.9%
Deferred Tax Assets, Valuation Allowance 166M USD +16.4%
Deferred Tax Assets, Gross 174M USD +13.4%
Operating Lease, Liability 22.5M USD
Payments to Acquire Property, Plant, and Equipment 28K USD -72.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.5M USD +18.6%
Lessee, Operating Lease, Liability, to be Paid 25.3M USD
Operating Lease, Liability, Current 6.76M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.48M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 8.27M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +37.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.75M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.51M USD
Deferred Tax Assets, Operating Loss Carryforwards 14.5M USD +2201%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Additional Paid in Capital 521M USD +2.17%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.41M USD +5.73%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%